These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3905605)

  • 1. [Problems of blood replacement in liver transplantation].
    Sporn P; Mauritz W; Schindler I; Zadrobilek E; Höcker P; Piza F; Funovics J; Fritsch A
    Infusionsther Klin Ernahr; 1985 Aug; 12(4):187-91. PubMed ID: 3905605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of blood components in 30 liver transplantations at the Hamburg Eppendorf University Clinic 1984 to 1989].
    Winkler M; Kühnl P; Kremer B; Henne-Bruns D; Lang T
    Beitr Infusionsther; 1990; 26():194-6. PubMed ID: 1703828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy using blood components. Prerequisites, indications and clinical use].
    Glück D; Kubanek B; Ahnefeld FW
    Infusionsther Klin Ernahr; 1986 Oct; 13(5):240-9. PubMed ID: 3804436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood replacement in liver and pancreas/kidney transplantation].
    Rosmanith P; Schönitzer D
    Beitr Infusionsther; 1989; 24():165-71. PubMed ID: 2481534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation.
    de Boer MT; Christensen MC; Asmussen M; van der Hilst CS; Hendriks HG; Slooff MJ; Porte RJ
    Anesth Analg; 2008 Jan; 106(1):32-44, table of contents. PubMed ID: 18165548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations.
    Massicotte L; Lenis S; Thibeault L; Sassine MP; Seal RF; Roy A
    Liver Transpl; 2006 Jan; 12(1):117-23. PubMed ID: 16382461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation defects do not predict blood product requirements during liver transplantation.
    Massicotte L; Beaulieu D; Thibeault L; Roy JD; Marleau D; Lapointe R; Roy A
    Transplantation; 2008 Apr; 85(7):956-62. PubMed ID: 18408574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of blood product use in orthotopic liver transplantation using the piggyback hepatectomy technique.
    Mangus RS; Kinsella SB; Nobari MM; Fridell JA; Vianna RM; Ward ES; Nobari R; Tector AJ
    Transplant Proc; 2007 Dec; 39(10):3207-13. PubMed ID: 18089355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Goal-directed" transfusion management leads to distinct reduction of fluid requirement in liver transplantation.
    Gerlach H; Rossaint R; Bechstein WO; Blumhardt G; Neuhaus P; Falke K
    Semin Thromb Hemost; 1993; 19(3):282-5. PubMed ID: 7689753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation of a risk index for the prediction of massive blood transfusion in liver transplantation.
    McCluskey SA; Karkouti K; Wijeysundera DN; Kakizawa K; Ghannam M; Hamdy A; Grant D; Levy G
    Liver Transpl; 2006 Nov; 12(11):1584-93. PubMed ID: 16952177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aprotinin reduces the need for blood products during liver transplantation.
    Scudamore CH; Randall TE; Jewesson PJ; Shackleton CR; Salvian AJ; Fagan M; Frighetto L; Growe GH; Scarth I; Erb SR
    Am J Surg; 1995 May; 169(5):546-9. PubMed ID: 7538269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma magnesium during human liver transplantation.
    Skak C; Ejlersen E; Mogensen T; Winkel P; Secher NH
    Clin Transplant; 1996 Apr; 10(2):157-9. PubMed ID: 8664510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell transfusion in liver transplantation: a case-control study.
    Nardo B; Bertelli R; Montalti R; Beltempo P; Puviani L; Pacilè V; Cavallari A
    Transplant Proc; 2005 Dec; 37(10):4389-92. PubMed ID: 16387128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New trends in blood component therapy.
    Högman CF
    Haematologia (Budap); 1983; 16(1-4):23-38. PubMed ID: 6383964
    [No Abstract]   [Full Text] [Related]  

  • 15. MELD score and blood product requirements during liver transplantation: no link.
    Massicotte L; Beaulieu D; Roy JD; Marleau D; Vandenbroucke F; Dagenais M; Lapointe R; Roy A
    Transplantation; 2009 Jun; 87(11):1689-94. PubMed ID: 19502961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictors of massive blood transfusion in liver transplantation for patients with benign end-stage liver disease].
    Feng ZY; Jin XD; Chen YZ
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(43):3040-4. PubMed ID: 19192401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New aspects of therapy with blood and blood components].
    Frick U; Frick G
    Zentralbl Chir; 1983; 108(23):1478-84. PubMed ID: 6666422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in hemostasis during orthotopic liver transplantation and massive transfusion: a case report].
    Kozek-Langenecker SA; Müller CM; Felfernig M; Zimpfer M
    Infusionsther Transfusionsmed; 1995 Oct; 22(5):296-300. PubMed ID: 8924744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluids administration and coagulation characteristics in patients with different model for end-stage liver disease scores undergoing orthotopic liver transplantation.
    Li M; Zhang LP; Yang L
    Chin Med J (Engl); 2007 Nov; 120(22):1963-8. PubMed ID: 18067779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: relationship to model of end-stage liver disease score and baseline coagulation status.
    Frasco PE; Poterack KA; Hentz JG; Mulligan DC
    Anesth Analg; 2005 Jul; 101(1):30-7, table of contents. PubMed ID: 15976201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.